Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Therapeutic Pipeline Market Review H1 2015 Available at LifeScienceIndustryResearch.com
Dallas, Texas (PRWEB) March 11, 2015 -- The report “Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) – Pipeline Review, H1 2015” provides comparative analysis on the therapeutic development for Radiation Toxicity. Radiation Toxicity is an acute illness caused by a dose greater than 50 rads of penetrating radiation to most or all of the body in a short time, usually a matter of minutes. Common exposures to low-dose radiation, such as X-ray or CT examinations, don't cause radiation sickness. The symptoms are Nausea and vomiting, Diarrhea, Headache, Fever, Dizziness and disorientation, Weakness, fatigue, Hair loss, bloody vomit and stools, infections, poor wound healing, low blood pressure. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report with TOC is available @ http://www.lifescienceindustryresearch.com/radiation-toxicity-radiation-sickness-acute-radiation-syndrome-pipeline-review-h1-2015.html .
The report also reviews key players involved in the therapeutic development for Radiation Toxicity and special features on late-stage and discontinued projects. Companies discussed in this Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) – Pipeline Review, H1 2015 report include Aeolus Pharmaceuticals, Inc., Bolder Biotechnology, Inc., Cantex Pharmaceuticals, Inc., Cellerant Therapeutics, Inc., Cleveland BioLabs, Inc., Gamida Cell Ltd., Humanetics Corporation, Meabco A/S, NeoStem, Inc., Neumedicines Inc., Onconova Therapeutics, Inc., Piramal Enterprises Limited, Pluristem Therapeutics Inc., Priaxon AG
ProCertus BioPharm Inc., RDD Pharma Ltd., RxBio, Inc., Soligenix, Inc., Terapio Corporation and Tonix Pharmaceuticals Holding Corp.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Drug Profiles mentioned in this report are 517-PXN, AEOL-10171, BBT-007, BBT-015, BBT-018, BBT-045, BCN-057, BIO-300, BP-C2, CLT-009, EDL-2000, entolimod, EWA-001, GC-003, GC-4403, GC-4419, JP4-039, NMIL-121, P-276, Peptide to Agonize GHSR-1a for Sepsis, Acute Radiation Syndrome and Acute Ischemic Stroke, PGX-100, PLX-RAD, PrC-210, recilisib sodium, Recombinant Protein for Sepsis, Inflammatory bowel disease, Acute radiation syndrome and Ischemic organ injury, romyelocel-L, RP-239X, rusalatide acetate, Rx-100, RX-101, SGX-201, Small Molecule for Radiation Proctitis, Small Molecules for Radiation and Chemical Toxicity, Small Molecules for Radiation Toxicity, Small Molecules to Inhibit NO Synthase for Toxicology, Metabolic and Dermatology, ST-7, Stem Cell Therapy for Radiation Exposure, SY-303A, SY-513 and TPO-7630. Order a purchase copy of this report @ http://www.lifescienceindustryresearch.com/purchase?rname=35679 . (This is a premium report priced at US$2000 for a single user License.)
List of Tables
Number of Products under Development for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome), H1 2015 11
Number of Products under Development for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Comparative Analysis, H1 2015 12
Number of Products under Development by Companies, H1 2015 14
Number of Products under Development by Companies, H1 2015 (Contd..1) 15
Number of Products under Investigation by Universities/Institutes, H1 2015 16
Products under Development by Companies, H1 2015 21
Products under Investigation by Universities/Institutes, H1 2015 24
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Aeolus Pharmaceuticals, Inc., H1 2015 25
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Bolder Biotechnology, Inc., H1 2015 26
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Cantex Pharmaceuticals, Inc., H1 2015 27
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Cellerant Therapeutics, Inc., H1 2015 28
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Cleveland BioLabs, Inc., H1 2015 29
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Gamida Cell Ltd., H1 2015 30
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Humanetics Corporation, H1 2015 31
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Meabco A/S, H1 2015 32
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by NeoStem, Inc., H1 2015 33
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Neumedicines Inc., H1 2015 34
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Onconova Therapeutics, Inc., H1 2015 35
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Piramal Enterprises Limited, H1 2015 36
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Pluristem Therapeutics Inc., H1 2015 37
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Priaxon AG, H1 2015 38
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by ProCertus BioPharm Inc., H1 2015 39
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by RDD Pharma Ltd., H1 2015 40
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by RxBio, Inc., H1 2015 41
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Soligenix, Inc., H1 2015 42
Explore more reports on Pharmaceuticals industry at http://www.lifescienceindustryresearch.com/category/pharmaceuticals .
About Us:
LifeScienceIndustryResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
Ritesh Tiwari, LifeScienceIndustryResearch.com, http://www.lifescienceindustryresearch.com, +1 (888) 391-5441, [email protected]
Share this article